Dr. Michael Garshick

265 posts

Dr. Michael Garshick

Dr. Michael Garshick

@garshick

Manhattan, NY Katılım Temmuz 2017
133 Takip Edilen307 Takipçiler
Dr. Michael Garshick retweetledi
NYU CVD Prevention
NYU CVD Prevention@NYUCVDPrevent·
🔎Spotlight on Sjögren’s at our #CardioRheumatology CME! Sjögren’s expert Teja Kapoor, MD will review the comprehensive systemic and cardiovascular manifestations of Sjögren’s. Sign up here ⤵️ nyulmc.org/cvinflammation…
NYU CVD Prevention tweet mediaNYU CVD Prevention tweet media
Svenska
0
3
9
1.3K
Dr. Michael Garshick retweetledi
Ron Blankstein
Ron Blankstein@RonBlankstein·
Excited to share our @JACCJournals #JACCIMG paper led by ⭐️@Bweber04 on AI detection of CAC on chest CT among 2,546 individuals with IMID (SLE/RA/Psoriasis) who did not have hx of ASCVD ~50% had CAC --> most not on statin! ➡️Over 8 yrs, AI CAC provided robust a/w MACE + ACM
Ron Blankstein tweet mediaRon Blankstein tweet mediaRon Blankstein tweet mediaRon Blankstein tweet media
English
5
28
91
16K
Dr. Michael Garshick retweetledi
NYU CVD Prevention
NYU CVD Prevention@NYUCVDPrevent·
How do statins enhance endothelial health & reduce #inflammation? Dr. Michael Garshick will present important findings from the Cardiometabolic Health Strategically Focused Research Network. Mon, 11/10, 11:06-11:11 AM Basic Sci Zone Moderated Digital Poster 26: VB.MDP.16
NYU CVD Prevention tweet media
English
0
2
5
234
Dr. Michael Garshick retweetledi
NYU CVD Prevention
NYU CVD Prevention@NYUCVDPrevent·
Register for the 5th Annual #CardioRheum symposium and get free access to Medscape’s 1 hour mini-symposium: ‘Race Against Inflammation: ASCVD & #CKD Risk Reduction Insights.’ Join in-person or virtually—don’t miss the main event + bonus content! Sign up: nyulmc.org/cvinflammation…
NYU CVD Prevention tweet media
English
0
7
11
841
Dr. Michael Garshick retweetledi
NYU Grossman School of Medicine
2/Psoriasis is a skin disease that causes inflammation, and it’s been linked to heart problems. Michael Garshick, MD, director of the Cardio-Rheumatology Program, explores how inflammation in psoriasis may promote plaque buildup in arteries. 📍Sat, 11AM CT | Session 1041
NYU Grossman School of Medicine tweet media
English
1
2
7
357
Dr. Michael Garshick retweetledi
NYU CVD Prevention
NYU CVD Prevention@NYUCVDPrevent·
NYU Langone cardiology faculty kick off #ACC25 in style! Stay tuned for exciting conference updates from @nyugrossman, highlighting the latest in #cardiovascular research and innovation.
NYU CVD Prevention tweet media
English
0
4
43
2.1K
Dr. Michael Garshick retweetledi
Pablo Corral MD
Pablo Corral MD@drpablocorral·
👉Two great manuscripts about inflammation and CVD 🔓Open Access 1️⃣Novel Therapeutics and Upcoming Clinical Trials Targeting Inflammation in Cardiovascular Diseases ☝️This review summarizes the main characteristics and findings of completed and upcoming randomized controlled trials directly targeting inflammation in CVDs, and discusses major challenges and future perspectives in the exciting and constantly expanding landscape of cardioimmunology ahajournals.org/doi/full/10.11… 2️⃣ Immune-Mediated Inflammatory Diseases, Dyslipidemia, and Cardiovascular Risk: A Complex Interplay ☝️ This review aims to critically evaluate the current understanding of the relationship between immune-mediated inflammatory diseases and dyslipidemia, the underlying mechanisms contributing to atherogenesis, and the impact of various pharmacotherapies on lipid profiles and cardiovascular risk. We also discuss the role of lipid-lowering therapies, particularly statins, in managing residual risk in this high-risk population and explore the potential of emerging therapies with complementary anti-inflammatory and lipid-lowering effects. ahajournals.org/doi/full/10.11… @society_eas @atvbahajournals
Pablo Corral MD tweet mediaPablo Corral MD tweet mediaPablo Corral MD tweet media
English
5
31
91
4.9K
Dr. Michael Garshick retweetledi
Michael Wilkinson
Michael Wilkinson@MWilkinsonMD·
Much to learn about relationship between Lp(a) & inflammation ?mechanisms ?impact on CVD risk. Pooled baseline data from phase 3 trials ⬆️ Lp(a) more prevalent in RA & psoriatic arthritis than ASCVD @Lpa_Doc @hsbhatia @PamTaubMD @DrMichaelShapir @garshick @Bweber04 @CBallantyneMD
UC San Diego Cardiology@UCSDCardiology

.@MWilkinsonMD presenting work on Lp(a) levels in individuals with inflammatory diseases #AHA24 @UCSDCardFellows

English
1
6
40
1.9K